UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000045779
Receipt number R000052264
Scientific Title Single center prospective observational peer support study of preliminary usefulness for anxiety in AYA generation cancer patients
Date of disclosure of the study information 2021/10/17
Last modified on 2023/10/18 15:40:55

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Single center prospective observational peer support study of preliminary usefulness for anxiety in AYA generation cancer patients

Acronym

Peer support study of AYA generation cancer patients

Scientific Title

Single center prospective observational peer support study of preliminary usefulness for anxiety in AYA generation cancer patients

Scientific Title:Acronym

Peer support study of AYA generation cancer patients

Region

Japan


Condition

Condition

AYA generation cancer patients

Classification by specialty

Medicine in general Psychosomatic Internal Medicine Psychiatry

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

This study is a single-center, prospective observational study of the preliminary usefulness of the peer support "AYA Hiroba" held at the National Cancer Center Hospital Patient Support Center for anxiety in AYA generation cancer patients.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Hospital Anxiety and Depression Scale-Anxiety (HADS-A)

Key secondary outcomes

Distress Thermometer(DT)


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

15 years-old <=

Age-upper limit

39 years-old >=

Gender

Male and Female

Key inclusion criteria

Cancer patients of the AYA generation who participated in the peer support "AYA Hiroba"

Key exclusion criteria

not applicable

Target sample size

24


Research contact person

Name of lead principal investigator

1st name Eriko
Middle name
Last name Satomi

Organization

National Cancer Center Hospital, Japan

Division name

Department of Palliative Medicine

Zip code

1040045

Address

5-1-1 Tsukiji, Chuo-ku, Tokyo, Japan

TEL

03-3542-2511

Email

esatomi@ncc.go.jp


Public contact

Name of contact person

1st name Takatoshi
Middle name
Last name Hirayama

Organization

National Cancer Center Hospital, Japan

Division name

Department of Psycho-Oncology

Zip code

1040045

Address

5-1-1 Tsukiji, Chuo-ku, Tokyo, Japan

TEL

03-3542-2511

Homepage URL


Email

thirayam@ncc.go.jp


Sponsor or person

Institute

National Cancer Center, Japan

Institute

Department

Personal name



Funding Source

Organization

National Cancer Center, Japan

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Institutional Review Board of National Cancer Center, Japan

Address

5-1-1 Tsukiji, Chuo-ku, Tokyo, Japan

Tel

03-3542-2511

Email

NCC_IRBoffice@ml.res.ncc.go.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

国立がん研究センター中央病院


Other administrative information

Date of disclosure of the study information

2021 Year 10 Month 17 Day


Related information

URL releasing protocol

https://www.liebertpub.com/doi/10.1089/jayao.2023.0065

Publication of results

Published


Result

URL related to results and publications

https://www.liebertpub.com/doi/10.1089/jayao.2023.0065

Number of participants that the trial has enrolled

24

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results

2023 Year 08 Month 10 Day

Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2021 Year 09 Month 27 Day

Date of IRB

2021 Year 10 Month 06 Day

Anticipated trial start date

2021 Year 10 Month 07 Day

Last follow-up date

2023 Year 04 Month 13 Day

Date of closure to data entry

2023 Year 04 Month 13 Day

Date trial data considered complete

2023 Year 04 Month 17 Day

Date analysis concluded

2023 Year 04 Month 30 Day


Other

Other related information

Published(https://www.liebertpub.com/doi/10.1089/jayao.2023.0065)


Management information

Registered date

2021 Year 10 Month 17 Day

Last modified on

2023 Year 10 Month 18 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000052264